Treated by Dr. Ravi Chandra Reddy Obili at Dr Ravi Chandra Reddy
Gastrointestinal Stromal Tumours, or GISTs, are uncommon growths that develop in the wall of the digestive tract, most often in the stomach or small intestine. They arise from special cells that help control the movement of food through the gut. Dr Ravi Chandra Reddy evaluates and manages patients with GIST, tailoring treatment to the size, location and characteristics of each tumour.
Tumours arising in the stomach wall, the most common site for GIST. They may be detected incidentally or cause symptoms depending on size and location.
Tumours developing in the small bowel. These may present with bleeding or obstruction and often require imaging for diagnosis.
Less commonly, GISTs occur in the colon, rectum, oesophagus or other parts of the digestive tract, each presenting unique management considerations.
Multiple factors can contribute to the development and progression of this condition.
Recognising the signs early gives you more treatment options.
Assessment begins with a clinical history and physical examination, followed by imaging to locate and measure the tumour. Not every patient requires every test; investigations are selected based on individual findings.
From conservative to surgical — we always start with the least invasive option first.
A structured, patient-first approach from first visit to full recovery.
Dr Ravi Chandra Reddy reviews your symptoms, medical history and any imaging or tests already done, then conducts a physical examination to understand the tumour's likely behaviour.
Imaging studies such as CT or MRI locate and measure the GIST. Where needed, endoscopy and biopsy confirm the diagnosis and identify the genetic markers that guide treatment.
A personalised plan is developed, considering tumour size, location, risk category and your overall health. Options may include observation, targeted therapy, surgery or a combination.
After treatment, regular imaging and clinical review track for any recurrence. Adjustments to therapy or additional interventions are discussed if changes occur.
What to expect at each phase of recovery.
If surgery was performed, initial recovery involves wound healing, pain management and a gradual return to normal diet. Timelines vary; individual guidance takes priority.
Patients resume most daily activities and may start or continue targeted therapy if recommended. Regular check-ups monitor for side effects and ensure the treatment plan remains appropriate.
Ongoing imaging and clinical review continue for years, as GISTs can recur even after successful initial treatment. Long-term follow-up is an essential part of management.
Complete surgical removal and appropriate use of targeted therapy can achieve long-term control in many cases. However, some tumours may recur or resist treatment.
Careful surgical technique aims to preserve digestive function and organ integrity. Extensive tumours or complex locations may limit what can be preserved.
Regular surveillance allows early detection of recurrence, which can often be managed with further treatment. Recurrent disease may require adjustments to the original plan.
Treatment aims to relieve symptoms and prevent complications. Side effects from medication or surgery can affect daily life and are managed as part of ongoing care.
Untreated GISTs may grow over time, increasing the risk of bleeding, obstruction or spread to other organs such as the liver. Even small tumours can become more difficult to manage if left unmonitored. Early assessment allows for timely intervention and better long-term outcomes.
Seek medical attention if you notice blood in your stool, persistent abdominal pain, unexplained weight loss or a palpable mass in your abdomen. If you have been diagnosed with a GIST and experience new or worsening symptoms, contact your doctor promptly for review.
Early treatment means more options and better outcomes. Book a consultation to understand your condition and explore the right path forward.
